JMP Securities Expands Healthcare Research with New Managing Director

JMP Securities LLC, a leading research-driven investment bank, has strengthened its healthcare research capabilities with the addition of Robert C. Faulkner as a managing director and senior research analyst. Faulkner brings extensive experience in covering the medical device industry, having previously worked with Prudential Equity Group and JPMorgan. His expertise will complement JMP Securities' existing biotechnology research, expanding the firm's coverage of the healthcare sector to include medical devices. Faulkner's appointment is a strategic move to enhance JMP Securities' research offerings and support the growth of its client base.

Key Takeaways:

• Robert C. Faulkner joins JMP Securities as a managing director and senior research analyst, bringing expertise in covering the medical device industry.
• Faulkner was previously a senior vice president and senior equity analyst at Prudential Equity Group, where he covered the medical device industry.
• His experience at JPMorgan and its predecessor, Hambrecht & Quist, further solidifies his knowledge in the sector.
• Faulkner began his career in the healthcare industry at SmithKline Beckman Corporation, where he worked in product management.
• His education background includes an MBA from the Amos Tuck School of Business at Dartmouth College and an AB from Harvard University.
• Faulkner's appointment extends JMP Securities' healthcare research beyond the 25 biotechnology companies already covered by senior analysts Charles Duncan, PhD and Adam Cutler.
• JMP Securities provides equity research, institutional brokerage, and investment banking services to public and private growth companies and their investors.

Statistics:

• 25 biotechnology companies already covered by senior analysts at JMP Securities
• 2 new areas of research coverage: medical devices and biotechnology
• 1 new managing director and senior research analyst: Robert C. Faulkner
• 1 month: time period before Faulkner join JMP Securities (April 11)

Sources:

• "NewsRx.com" via Health & Medicine Week editors
• "Health & Medicine Week" via NewsRx.com
• JMP Securities LLC